Outcomes of Limbal Stem Cell Transplant: A Meta-analysis.
Sign Up to like & getrecommendations! Published in 2020 at "JAMA ophthalmology"
DOI: 10.1001/jamaophthalmol.2020.1120
Abstract: Importance Limbal stem cell transplant (LSCT) can be categorized as direct autologous limbal transplant (AULT), direct allogenic limbal transplant (ALLT), cultivated autologous limbal stem cells transplant (cAULT), and cultivated allogenic limbal stem cells transplant (cALLT).… read more here.
Keywords: limbal stem; stem cell; stem; cell transplant ... See more keywords
Survival Trends in Infants Undergoing Allogeneic Hematopoietic Cell Transplant
Sign Up to like & getrecommendations! Published in 2019 at "JAMA Pediatrics"
DOI: 10.1001/jamapediatrics.2019.0081
Abstract: Importance Studies demonstrating improved survival after allogeneic hematopoietic cell transplant generally exclude infants. Objective To analyze overall survival trends and other outcomes among infants who undergo allogeneic hematopoietic cell transplant. Design, Setting, and Participants In… read more here.
Keywords: allogeneic hematopoietic; transplant; hematopoietic cell; survival ... See more keywords
Applying a risk prediction model for bloodstream infection in a febrile, nonseverely neutropenic cohort of pediatric stem cell transplant patients
Sign Up to like & getrecommendations! Published in 2023 at "Cancer"
DOI: 10.1002/cncr.34703
Abstract: The optimal management of febrile stem cell transplant (SCT) patients presenting without severe neutropenia (absolute neutrophil count [ANC] ≥ 500/µL) is unclear. The authors have developed iterative risk prediction models (Esbenshade Vanderbilt [EsVan] models) that… read more here.
Keywords: risk prediction; cell transplant; stem cell;
Adenovirus infection among allogeneic stem cell transplant recipients
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Medical Virology"
DOI: 10.1002/jmv.24579
Abstract: The human adenovirus (HAdV) infection can cause severe disease in immunocompromised patients, such as those undergoing allogeneic hematopoietic stem cell transplant (ASCT). The main objective of this study was to prospectively monitor ASCT recipients for… read more here.
Keywords: stem cell; infection; cell transplant;
Prolonged versus short infusion rates for intravenous magnesium sulfate administration in hematopoietic cell transplant patients
Sign Up to like & getrecommendations! Published in 2018 at "Supportive Care in Cancer"
DOI: 10.1007/s00520-018-4127-z
Abstract: PurposeHematopoietic cell transplant (HCT) recipients often require intravenous (IV) magnesium repletion due to poor dietary intake, gastrointestinal loss, and use of concomitant magnesium wasting medications. Prolonging the IV magnesium infusion rate has been postulated to… read more here.
Keywords: infusion; intravenous magnesium; magnesium; cell transplant ... See more keywords
Palliative care for patients around the time of haematopoietic stem cell transplant: a qualitative study of patients’ perceptions and experiences of unmet need and attitudes towards palliative care involvement
Sign Up to like & getrecommendations! Published in 2021 at "Supportive Care in Cancer"
DOI: 10.1007/s00520-021-06556-4
Abstract: Haemato-oncology patients are likely to be referred later to palliative care than patients with solid tumours, despite experiencing similar symptom burden. Patients prior to stem cell transplant may benefit from symptom control, advance care planning… read more here.
Keywords: palliative care; care; cell transplant; stem cell ... See more keywords
Proven Invasive Pulmonary Aspergillosis in Stem Cell Transplant Recipient Due to Aspergillus sublatus, a Cryptic Species of A. nidulans
Sign Up to like & getrecommendations! Published in 2017 at "Mycopathologia"
DOI: 10.1007/s11046-017-0223-8
Abstract: Invasive fungal disease represents one of the severe complications in haematopoietic stem cell transplant recipients. We describe a case of a patient treated for relapse of chronic lymphoblastic leukaemia 6 years after HSCT. The patient was… read more here.
Keywords: pulmonary aspergillosis; stem cell; invasive pulmonary; cryptic species ... See more keywords
Oral levetiracetam for prevention of busulfan-induced seizures in adult hematopoietic cell transplant
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Clinical Pharmacy"
DOI: 10.1007/s11096-020-00977-7
Abstract: Background Antiseizure prophylaxis is recommended when high-dose of busulfan is given as part of the conditioning regimens in the allogenic hematopoietic stem cell transplant. Phenytoin has been widely used but its pharmacokinetics and pharmacodynamics profile… read more here.
Keywords: busulfan; oral levetiracetam; levetiracetam; prevention busulfan ... See more keywords
Immune Checkpoint Blockade and Hematopoietic Stem Cell Transplant
Sign Up to like & getrecommendations! Published in 2017 at "Current Hematologic Malignancy Reports"
DOI: 10.1007/s11899-017-0362-5
Abstract: Allogeneic hematopoietic stem cell transplant (HSCT) relies primarily upon graft-versus-tumor activity for cancer eradication. Relapse remains the principal cause of treatment failure after HSCT, implying frequent immune escape, which in at least some cases, appears… read more here.
Keywords: checkpoint blockade; immune checkpoint; stem cell; hematopoietic stem ... See more keywords
The Landscape of Hematopoietic Stem Cell Transplant and Gene Therapy for X-Linked Adrenoleukodystrophy
Sign Up to like & getrecommendations! Published in 2019 at "Current Treatment Options in Neurology"
DOI: 10.1007/s11940-019-0605-y
Abstract: To present an updated appraisal of hematopoietic stem cell transplant (HSCT) and gene therapy for X-linked adrenoleukodystrophy (ALD) in the setting of a novel, presymptomatic approach to disease. Outcomes in HSCT for ALD have been… read more here.
Keywords: gene therapy; stem cell; hematopoietic stem; gene ... See more keywords
Utilizing Data to Modify Standard Operating Procedures and Improve Outcomes: Evaluating Complications after Donor Lymphocyte Infusions in Allogeneic Stem Cell Transplant Recipients
Sign Up to like & getrecommendations! Published in 2019 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2018.12.412
Abstract: Introduction Despite major advances in hematopoietic cell transplant (HCT), 10-50% of patients relapse following allogeneic HCT. Donor lymphocyte infusion (DLI) is one treatment strategy for relapse that potentially provides a graft versus malignancy therapeutic effect.… read more here.
Keywords: cell transplant; donor lymphocyte; policy; cell ... See more keywords